Literature DB >> 17571219

[Diagnostics and therapy of idiopathic pulmonary hemosiderosis].

Hinrich Willms1, Kathleen Gutjahr, Uwe R Juergens, Stefan Hammerschmidt, Christian Gessner, Gerhard Hoheisel, Hubert Wirtz, Adrian Gillissen.   

Abstract

Idiopathic pulmonary hemosiderosis (IPH) is a rare clinical entity characterized by recurrent episodes of diffuse alveolar hemorrhage. The disease--also called Ceelen's syndrome--was subsequently defined as a clinical entity comprising the triade of hemoptysis, opacities in X-ray, and anemia, in which the etiology is still unknown. Intensive search for a specific etiology ends up negative, and there are no features, which are specifically pathognomonic for IPH. Therefore, the diagnosis relies solely on the exclusion of other disorders in which diffuse alveolar hemorrhage is a cardinal sign. Acute episodes may occur frequently, eventually leading to lung fibrosis in the chronic stage. Usually, the therapy consists of high doses of corticosteroids, which can be combined with immunosuppressive drugs. In addition to this review, a case having Ceelen's syndrome is presented. After a complicated clinical course, the patient could finally be stabilized with a combination therapy of prednisolone and azathioprine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17571219     DOI: 10.1007/s00063-007-1057-9

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  2 in total

1.  Severe Respiratory Distress in a Child with Pulmonary Idiopathic Hemosiderosis Initially Presenting with Iron-Deficiency Anemia.

Authors:  A Potalivo; L Finessi; F Facondini; A Lupo; C Andreoni; G Giuliani; C Cavicchi
Journal:  Case Rep Pulmonol       Date:  2015-11-08

2.  Idiopathic pulmonary hemosiderosis - a diagnostic challenge.

Authors:  Ilirjana Bakalli; Luljeta Kota; Durim Sala; Ermela Celaj; Elmira Kola; Robert Lluka; Sashenka Sallabanda
Journal:  Ital J Pediatr       Date:  2014-04-04       Impact factor: 3.288

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.